Notice: This company has been marked as potentially delisted and may not be actively trading. Gritstone bio (GRTS) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrends Get the Latest News and Ratings for GRTS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Gritstone bio and its competitors. Enter your email to sign up for newsletter Sign Up GRTS Analyst Ratings Over TimeTypeCurrent Forecast11/27/23 to 11/26/241 Month Ago10/28/23 to 10/27/243 Months Ago8/29/23 to 8/28/241 Year Ago11/27/22 to 11/27/23Strong Buy1 Strong Buy rating(s)1 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy0 Buy rating(s)0 Buy rating(s)4 Buy rating(s)4 Buy rating(s)Hold3 Hold rating(s)3 Hold rating(s)0 Hold rating(s)0 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price Target$2.17$2.17$4.75$7.33Forecasted UpsideN/A6,628.78% Upside928.14% Upside439.22% UpsideConsensus RatingModerate BuyModerate BuyBuyBuy ❗[Investor Alert] Under-the-Radar Tech (Ad)While most investors are caught up in cryptocurrencies, AI stocks, or Jim Cramer's latest "hot pick…" One company that most have never heard of is making waves in the global music market…TuneGO Click here for all the details about today's open round of investing. GRTS Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History GRTS Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Gritstone bio Stock vs. The CompetitionTypeGritstone bioMedical CompaniesS&P 500Consensus Rating Score 2.50 2.80 2.50Consensus RatingModerate BuyModerate BuyModerate BuyPredicted UpsideN/A24,931.24% Upside6.94% UpsideNews Sentiment RatingNeutral NewsSee Recent GRTS NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails10/2/2024B. Riley4 of 5 stars Reiterated RatingBuy ➝ Neutral$3.00 ➝ $1.00+354.74%10/1/2024Evercore ISI2 of 5 starsJ. MillerSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy10/1/2024HC Wainwright2 of 5 starsS. LeeSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Neutral$4.00 ➝ $0.50+98.49%10/1/2024JMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingR. BuchananSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOutperform ➝ Market Perform9/28/2023Piper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetOverweight ➝ Overweight$6.00 ➝ $7.00+488.23%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 06:33 PM ET. GRTS Forecast - Frequently Asked Questions What is Gritstone bio's forecast for 2025? According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Gritstone bio is $2.17, with a high forecast of $5.00 and a low forecast of $0.50. Should I buy or sell Gritstone bio stock right now? 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Gritstone bio in the last year. There are currently 3 hold ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" GRTS shares. Does Gritstone bio's stock price have much upside? According to analysts, Gritstone bio's stock has a predicted upside of ∞ based on their 12-month stock forecasts. Has Gritstone bio been upgraded or downgraded by Wall Street analysts recently? Over the previous 90 days, Gritstone bio's stock had 2 downgrades and 1 upgrade by analysts. What analysts cover Gritstone bio? Gritstone bio has been rated by research analysts at B. Riley, Evercore ISI, HC Wainwright, and JMP Securities in the past 90 days. Do Wall Street analysts like Gritstone bio more than its competitors? Analysts like Gritstone bio less than other "medical" companies. The consensus rating score for Gritstone bio is 2.50 while the average consensus rating score for "medical" companies is 2.80. Learn more on how GRTS compares to other companies. Stock Forecasts and Research Tools Related Companies Sensei Biotherapeutics Stock Forecast Talphera Stock Forecast Aspira Women's Health Stock Forecast Imunon Stock Forecast ImmunoPrecise Antibodies Stock Forecast Turnstone Biologics Stock Forecast Cardio Diagnostics Stock Forecast BioCardia Stock Forecast Indaptus Therapeutics Stock Forecast Kiora Pharmaceuticals Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter ❗[Investor Alert] Under-the-Radar Tech (Ad)While most investors are caught up in cryptocurrencies, AI stocks, or Jim Cramer's latest "hot pick…" One company that most have never heard of is making waves in the global music market…TuneGO Click here for all the details about today's open round of investing. This page (NASDAQ:GRTS) was last updated on 11/26/2024 by MarketBeat.com Staff From Our Partners❗[Investor Alert] Under-the-Radar TechWhile most investors are caught up in cryptocurrencies, AI stocks, or Jim Cramer's latest "hot pick…" One c...TuneGO | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThis Crisis Could Be Worse Than 2008Underneath the surface, cracks are forming. Cracks that threaten to shatter everything we know. America ...Behind the Markets | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | Sponsored140% Yields From Stocks Like Tesla? Here's How (Black Friday Special)140% Dividends from stocks like Tesla? Discover How for Just $9! For Black Friday, get the full details of ...Investors Alley | Sponsored9 hidden AI stocks set to thrive in Trump’s new eraAI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be wor...StockEarnings | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gritstone bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gritstone bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
